Long COVID as an Infection-Associated Chronic Condition: Implications

Davis HE Assaf GS McCorkell L , et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.

National Academies of Sciences, Engineering, and Medicine . A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. Washington, DC: The National Academies Press; 2024. doi:10.17226/27768

Institute of Medicine . The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects: Workshop Summary. Washington, DC: The National Academies Press; 2004. doi:10.17226/11026

O’Connor SM Taylor CE Hughes JM . Emerging infectious determinants of chronic diseases. Emerg Infect Dis. 2006;12:1051-1057.

National Academies of Sciences, Engineering, and Medicine . Toward a Common Research Agenda in Infection-Associated Chronic Illnesses: Proceedings of a Workshop. Washington, DC: The National Academies Press; 2024. doi:10.17226/27462

Choutka J Jansari V Hornig M Iwasaki A . Unexplained post-acute infection syndromes. Nat Med. 2022;28:911-923.

Talla A Vasaikar SV Szeto GL , et al. Persistent serum protein signatures define an inflammatory subcategory of long COVID. Nat Commun. 2023;14:3417.

Gentilotti E Górska A Tami A , et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. eClinicalMedicine. 2023;62:102107.

Kitsios GD Blacka S Jacobs JJ , et al. Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis. BMJ Open. 2024;14:e077869.

Frontera JA Thorpe LE Simon NM , et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: a prospective, observational study. PLoS One. 2022;17:e0275274.

Institute of Medicine . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press; 2015. doi:10.17226/19012

Liles EG Irving SA Dandamudi PD , et al. Classification accuracy and description of myalgic encephalomyelitis/chronic fatigue syndrome in an integrated healthcare system, 2006-2017. Perm J. 2024;23:170.

Davis HE McCorkell L Vogel JM Topol EJ . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133-146.

Al-Aly Z Davis H McCorkell L , et al. Long COVID science, research and policy. Nat Med. 2024;30:2148-2164.

Allen ME Rus V Szeto GL . Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol Med. 2021;27:152-171.

Unger ER Lin JMS Chen Y , et al. Heterogeneity in measures of illness among patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is not explained by clinical practice: a study in seven U.S. specialty clinics. J Clin Med. 2024;13:1369.

Vogel JM Pollack B Spier E , et al. Designing and optimizing clinical trials for long COVID. Life Sci. 2024;355:122970.